Post-stroke inflammation and the potential efficacy of novel stem cell therapies: Focus on amnion epithelial cells

Frontiers in Cellular Neuroscience

Volumn , Issue DEC, 2012, Pages

  Broughton, Brad R S ^a   Lim, Rebecca ^b   Arumugam, Thiruma V ^c   Drummond, Grant R ^a   Wallace, Euan M ^b   Sobey, Christopher G ^a  

^a MONASH UNIVERSITY   (Australia)

^b HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; TISSUE PLASMINOGEN ACTIVATOR;

ADAPTIVE IMMUNITY; AMNION CELL; ANTICOAGULATION; BRAIN ISCHEMIA; CELL MIGRATION; CLINICAL EFFECTIVENESS; CONVALESCENCE; CYTOKINE RELEASE; GRAFT SURVIVAL; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMMUNOMODULATION; INNATE IMMUNITY; NERVE CELL DIFFERENTIATION; NERVE REGENERATION; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; REINNERVATION; REVIEW; RISK REDUCTION; STEM CELL TRANSPLANTATION; THROMBOCYTE AGGREGATION INHIBITION; TREATMENT OUTCOME;

EID: 84872198899     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2012.00066     Document Type: Review

References (85)

1. Ajmo, C.T., Jr., Vernon, D.O., Collier, L., Hall, A.A., Garbuzova-Davis, S., Willing, A., and Pennypacker, K.R. (2008). The spleen contributes to stroke-induced neurodegeneration. J Neurosci Res 86, 2227-2234.
2. Akle, C.A., Adinolfi, M., Welsh, K.I., Leibowitz, S., and Mccoll, I. (1981). Immunogenicity of human amniotic epithelial cells after transplantation into volunteers. Lancet 2, 1003-1005.
3. Amariglio, N., Hirshberg, A., Scheithauer, B.W., Cohen, Y., Loewenthal, R., Trakhtenbrot, L., Paz, N., Koren-Michowitz, M., Waldman, D., Leider-Trejo, L., Toren, A., Constantini, S., and Rechavi, G. (2009). Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med 6, e1000029.
4. Bailo, M., Soncini, M., Vertua, E., Signoroni, P.B., Sanzone, S., Lombardi, G., Arienti, D., Calamani, F., Zatti, D., and Paul, P. (2004). Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation 78, 1439-1448.
5. Banas, R.A., Trumpower, C., Bentlejewski, C., Marshall, V., Sing, G., and Zeevi, A. (2008). Immunogenicity and immunomodulatory effects of amnion-derived multipotent progenitor cells. Hum Immunol 69, 321-328.
6. Barry, M., and Bleackley, R.C. (2002). Cytotoxic T lymphocytes: all roads lead to death. Nat Rev Immunol 2, 401-409.
7. Brait, V.H., Arumugam, T.V., Drummond, G.R., and Sobey, C.G. (2012). Importance of T lymphocytes in brain injury, immunodeficiency, and recovery after cerebral ischemia. J Cereb Blood Flow Metab 32, 598-611.
8. Brait, V.H., Jackman, K.A., Walduck, A.K., Selemidis, S., Diep, H., Mast, A.E., Guida, E., Broughton, B.R., Drummond, G.R., and Sobey, C.G. (2010). Mechanisms contributing to cerebral infarct size after stroke: gender, reperfusion, T lymphocytes, and Nox2-derived superoxide. J Cereb Blood Flow Metab 30, 1306-1317.
9. Broughton, B.R., Reutens, D.C., and Sobey, C.G. (2009). Apoptotic mechanisms after cerebral ischemia. Stroke 40, e331-339.
10. Burns, T.C., Verfaillie, C.M., and Low, W.C. (2009). Stem cells for ischemic brain injury: a critical review. J Comp Neurol 515, 125-144.
11. Daadi, M.M., Maag, A.L., and Steinberg, G.K. (2008). Adherent self-renewable human embryonic stem cell-derived neural stem cell line: functional engraftment in experimental stroke model. PLoS One 3, e1644.
12. Del Zoppo, G.J., Saver, J.L., Jauch, E.C., and Adams, H.P., Jr. (2009). Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke 40, 2945-2948.
13. Dirks, P.B. (2001). Glioma migration: clues from the biology of neural progenitor cells and embryonic CNS cell migration. J Neurooncol 53, 203-212.
14. Dirnagl, U. (2006). Bench to bedside: the quest for quality in experimental stroke research. J Cereb Blood Flow Metab 26, 1465-1478.
15. Dong, W., Chen, H., Yang, X., Guo, L., and Hui, G. (2010). Treatment of intracerebral haemorrhage in rats with intraventricular transplantation of human amniotic epithelial cells. Cell Biol Int 34, 573-577.
16. Elwan, M.A., and Sakuragawa, N. (1997). Evidence for synthesis and release of catecholamines by human amniotic epithelial cells. Neuroreport 8, 3435-3438.
17. Fischer, U.M., Harting, M.T., Jimenez, F., Monzon-Posadas, W.O., Xue, H., Savitz, S.I., Laine, G.A., and Cox, C.S., Jr. (2009). Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev 18, 683-692.
18. Gelderblom, M., Leypoldt, F., Steinbach, K., Behrens, D., Choe, C.U., Siler, D.A., Arumugam, T.V., Orthey, E., Gerloff, C., Tolosa, E., Magnus, T. (2009). Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 40:1849-1857.
19. Gelderblom, M., Weymar, A., Bernreuther, C., Velden, J., Arunachalam, P., Steinbach, K., Orthey, E., Arumugam, T.V., Leypoldt, F., Simova, O., Thom, V., Friese, M.A., Prinz, I., Hölscher, C., Glatzel, M., Korn, T., Gerloff, C., Tolosa, E., Magnus, T.(2012). Neutralization of the IL-17 axis diminishes neutrophil invasion and protects from ischemic stroke. Blood 120,3793-3802.
20. Gendron, A., Teitelbaum, J., Cossette, C., Nuara, S., Dumont, M., Geadah, D., Du Souich, P., and Kouassi, E. (2002). Temporal effects of left versus right middle cerebral artery occlusion on spleen lymphocyte subsets and mitogenic response in Wistar rats. Brain Res 955, 85-97.
21. Hicks, A.U., Lappalainen, R.S., Narkilahti, S., Suuronen, R., Corbett, D., Sivenius, J., Hovatta, O., and Jolkkonen, J. (2009). Transplantation of human embryonic stem cellderived neural precursor cells and enriched environment after cortical stroke in rats: cell survival and functional recovery. Eur J Neurosci 29, 562-574.
22. Hill, W., Hess Dc, Martin-Studdard A, Carothers Jj, Hale D, Maeda M, Fagan Sc, Je, C., and Sj, C. (2004). SDF-1 (CXCL12) Is Upregulated in the Ischemic Penumbra Following Stroke: Association with Bone Marrow Cell Homing to Injury. Journal of Neuropathology and Experimental Neurology 63, 84-96.
23. Hiyama, E., and Hiyama, K. (2007). Telomere and telomerase in stem cells. British Journal of Cancer 96, 1020-1024.
24. Hori, J., Wang, M., Kamiya, K., Takahashi, H., and Sakuragawa, N. (2006). Immunological characteristics of amniotic epithelium. Cornea 25, S53-58.
25. Houlihan, J.M., Biro, P.A., Harper, H.M., Jenkinson, H.J., and Holmes, C.H. (1995). The human amnion is a site of MHC class Ib expression: evidence for the expression of HLA-E and HLA-G. J Immunol 154, 5665-5674.
26. Iadecola, C., and Anrather, J. (2011). The immunology of stroke: from mechanisms to translation. Nat Med 17, 796-808.
27. Irony-Tur-Sinai, M., Grigoriadis, N., Tsiantoulas, D., Touloumi, O., Abramsky, O., and Brenner, T. (2009). Immunomodulation of EAE by alpha-fetoprotein involves elevation of immune cell apoptosis markers and the transcription factor FoxP3. J Neurol Sci 279, 80-87.
28. Jin, R., Yang, G., and Li, G. (2010). Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol 87, 779-789.
29. Kakishita, K., Elwan, M.A., Nakao, N., Itakura, T., and Sakuragawa, N. (2000). Human amniotic epithelial cells produce dopamine and survive after implantation into the striatum of a rat model of Parkinson's disease: a potential source of donor for transplantation therapy. Experimental Neurology 165, 27-34.
30. Kakishita, K., Nakao, N., Sakuragawa, N., and Itakura, T. (2003). Implantation of human amniotic epithelial cells prevents the degeneration of nigral dopamine neurons in rats with 6-hydroxydopamine lesions. Brain Res 980, 48-56.
31. Kawai, H., Yamashita, T., Ohta, Y., Deguchi, K., Nagotani, S., Zhang, X., Ikeda, Y., Matsuura, T., and Abe, K. (2010). Tridermal tumorigenesis of induced pluripotent stem cells transplanted in ischemic brain. J Cereb Blood Flow Metab 30, 1487-1493.
32. Kiskinis, E., and Eggan, K. (2010). Progress toward the clinical application of patientspecific pluripotent stem cells. J Clin Invest 120, 51-59.
33. Kleindorfer, D., Lindsell, C.J., Brass, L., Koroshetz, W., and Broderick, J.P. (2008). National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate. Stroke 39, 924-928.
34. Kleinschnitz, C., Schwab, N., Kraft, P., Hagedorn, I., Dreykluft, A., Schwarz, T., Austinat, M., Nieswandt, B., Wiendl, H., Stoll, G. (2010). Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation. Blood 115:3835-3842.
35. Kleinschnitz, C., Kraft, P., Dreykluft, A., Hagedorn, I., Göbel, K., Schuhmann, M.K., Langhauser, F., Helluy, X., Schwarz, T., Bittner, S., Mayer, C.T., Brede, M., Varallyay, C., Pham, M., Bendszus, M., Jakob, P., Magnus, T., Meuth, S.G., Iwakura, Y., Zernecke, A., Sparwasser, T., Nieswandt, B., Stoll, G., Wiendl, H. (2012). Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature. Blood. Nov 15 [Epub ahead of print].
36. Knoepfler, P.S. (2009). Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine. Stem Cells 27, 1050-1056.
37. Lee, J.S., Hong, J.M., Moon, G.J., Lee, P.H., Ahn, Y.H., and Bang, O.Y. (2010). A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells 28, 1099-1106.
38. Li, H., Niederkorn, J.Y., Neelam, S., Mayhew, E., Word, R.A., Mcculley, J.P., and Alizadeh, H. (2005). Immunosuppressive factors secreted by human amniotic epithelial cells. Invest Ophthalmol Vis Sci 46, 900-907.
39. Liesz, A., Hagmann, S., Zschoche, C., Adamek, J., Zhou, W., Sun, L., Hug, A., Zorn, M., Dalpke, A., Nawroth, P., and Veltkamp, R. (2009). The spectrum of systemic immune alterations after murine focal ischemia: immunodepression versus immunomodulation. Stroke 40, 2849-2858.
40. Lindvall, O., and Kokaia, Z. (2004). Recovery and rehabilitation in stroke: stem cells. Stroke 35, 2691-2694.
41. Lindvall, O., and Kokaia, Z. (2011). Stem cell research in stroke: how far from the clinic? Stroke 42, 2369-2375.
42. Liu, T., Wu, J., Huang, Q., Hou, Y., Jiang, Z., Zang, S., and Guo, L. (2008). Human amniotic epithelial cells ameliorate behavioral dysfunction and reduce infarct size in the rat middle cerebral artery occlusion model. Shock 29, 603-611.
43. Liu, Y.H., Vaghjiani, V., Tee, J.Y., To, K., Cui, P., Oh, D.Y., Manuelpillai, U., Toh, B.H., and Chan, J. (2012). Amniotic epithelial cells from the human placenta potently suppress a mouse model of multiple sclerosis. PLoS One 7, e35758.
44. Liu, Y.P., Seckin, H., Izci, Y., Du, Z.W., Yan, Y.P., and Baskaya, M.K. (2009). Neuroprotective effects of mesenchymal stem cells derived from human embryonic stem cells in transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab 29, 780-791.
45. Magnus, T., Wiendl, H., Kleinschnitz, C. (2012). Immune mechanisms of stroke. Curr Opin Neurol 25,334-340.
46. Mccluskey, L., Campbell, S., Anthony, D., and Allan, S.M. (2008). Inflammatory responses in the rat brain in response to different methods of intra-cerebral administration. J Neuroimmunol 194, 27-33.
47. Mcdonald, C., Siatskas, C., and Bernard, C.C.A. (2011). The emergence of amnion epithelial stem cells for the treatment of Multiple Sclerosis Inflammation and Regeneration 31, 256-271.
48. Meisel, C., and Meisel, A. (2011). Suppressing immunosuppression after stroke. N Engl J Med 365, 2134-2136.
49. Meng, X.T., Chen, D., Dong, Z.Y., and Liu, J.M. (2007). Enhanced neural differentiation of neural stem cells and neurite growth by amniotic epithelial cell co-culture. Cell Biol Int 31, 691-698.
50. Miki, T., Lehmann, T., Cai, H., Stolz, D.B., and Strom, S.C. (2005). Stem cell characteristics of amniotic epithelial cells. Stem Cells 23, 1549-1559.
51. Moodley, Y., Ilancheran, S., Samuel, C., Vaghjiani, V., Atienza, D., Williams, E.D., Jenkin, G., Wallace, E., Trounson, A., and Manuelpillai, U. (2010). Human amnion epithelial cell transplantation abrogates lung fibrosis and augments repair. Am J Respir Crit Care Med 182, 643-651.
52. Murphy, S., Lim, R., Dickinson, H., Acharya, R., Rosli, S., Jenkin, G., and Wallace, E. (2011). Human amnion epithelial cells prevent bleomycin-induced lung injury and preserve lung function. Cell Transplant 20, 909-923.
53. Offner, H., Subramanian, S., Parker, S.M., Wang, C., Afentoulis, M.E., Lewis, A., Vandenbark, A.A., and Hurn, P.D. (2006). Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J Immunol 176, 6523-6531.
54. Parolini, O., Alviano, F., Bagnara, G.P., Bilic, G., Buhring, H.J., Evangelista, M., Hennerbichler, S., Liu, B., Magatti, M., Mao, N., Miki, T., Marongiu, F., Nakajima, H., Nikaido, T., Portmann-Lanz, C.B., Sankar, V., Soncini, M., Stadler, G., Surbek, D., Takahashi, T.A., Redl, H., Sakuragawa, N., Wolbank, S., Zeisberger, S., Zisch, A., and Strom, S.C. (2008). Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells 26, 300-311.
55. Prass, K., Meisel, C., Hoflich, C., Braun, J., Halle, E., Wolf, T., Ruscher, K., Victorov, I.V., Priller, J., Dirnagl, U., Volk, H.D., and Meisel, A. (2003). Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 198, 725-736.
56. Reeves, M.J., Arora, S., Broderick, J.P., Frankel, M., Heinrich, J.P., Hickenbottom, S., Karp, H., Labresh, K.A., Malarcher, A., Mensah, G., Moomaw, C.J., Schwamm, L., and Weiss, P. (2005). Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry. Stroke 36, 1232-1240.
57. Rehni, A.K., Singh, N., Jaggi, A.S., and Singh, M. (2007). Amniotic fluid derived stem cells ameliorate focal cerebral ischaemia-reperfusion injury induced behavioural deficits in mice. Behav Brain Res 183, 95-100.
58. Robin, Zhang Zg, Wang L, Zhang Rl, Katakowski M, Zhang L, Wang Y C Z., and M, C. (2006). Stromal cell-derived factor 1a mediates neural progenitor cell motility after focal cerebral ischemia. Journal of Cerebral Blood Flow & Metabolism 26, 125-134.
59. Sakuragawa, N., Thangavel, R., Mizuguchi, M., Hirasawa, M., and Kamo, I. (1996). Expression of markers for both neuronal and glial cells in human amniotic epithelial cells. Neurosci Lett 209, 9-12.
60. Sankar, V., and Muthusamy, R. (2003). Role of human amniotic epithelial cell transplantation in spinal cord injury repair research. Neuroscience 118, 11-17.
61. Schmidt, N.O., Przylecki, W., Yang, W., Ziu, M., Teng, Y., Kim, S.U., Black, P.M., Aboody, K.S., and Carroll, R.S. (2005). Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor. Neoplasia 7, 623-629.
62. Schwarting, S., Litwak, S., Hao, W., Bahr, M., Weise, J., and Neumann, H. (2008). Hematopoietic stem cells reduce postischemic inflammation and ameliorate ischemic brain injury. Stroke 39, 2867-2875.
63. Seifert, H.A., Leonardo, C.C., Hall, A.A., Rowe, D.D., Collier, L.A., Benkovic, S.A., Willing, A.E., and Pennypacker, K.R. (2012). The spleen contributes to stroke induced neurodegeneration through interferon gamma signaling. Metab Brain Dis.
64. Sloan, M.A. (1987). Thrombolysis and stroke. Past and future. Arch Neurol 44, 748-768.
65. Solomon, A., Rosenblatt, M., Monroy, D., Ji, Z., Pflugfelder, S.C., and Tseng, S.C. (2001). Suppression of interleukin 1alpha and interleukin 1beta in human limbal epithelial cells cultured on the amniotic membrane stromal matrix. Br J Ophthalmol 85, 444-449.
66. Stevens, S.L., Bao, J., Hollis, J., Lessov, N.S., Clark, W.M., and Stenzel-Poore, M.P. (2002). The use of flow cytometry to evaluate temporal changes in inflammatory cells following focal cerebral ischemia in mice. Brain Res 932, 110-119.
67. Tajiri, N., Acosta, S., Glover, L.E., Bickford, P.C., Jacotte Simancas, A., Yasuhara, T., Date, I., Solomita, M.A., Antonucci, I., Stuppia, L., Kaneko, Y., and Borlongan, C.V. (2012). Intravenous grafts of amniotic fluid-derived stem cells induce endogenous cell proliferation and attenuate behavioral deficits in ischemic stroke rats. PLoS One 7, e43779.
68. Takahashi, K., and Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676.
69. Tao, J., Ji, F., Liu, B., Wang, F., Dong, F., and Zhu, Y. (2012). Improvement of deficits by transplantation of lentiviral vector-modified human amniotic mesenchymal cells after cerebral ischemia in rats. Brain Res 1448, 1-10.
70. Tcheng, M., Oliver, L., Courtois, Y., and Jeanny, J.C. (1994). Effects of exogenous FGFs on growth, differentiation, and survival of chick neural retina cells. Exp Cell Res 212, 30-35.
71. Terada, S., Matsuura, K., Enosawa, S., Miki, M., Hoshika, A., Suzuki, S., and Sakuragawa, N. (2000). Inducing proliferation of human amniotic epithelial (HAE) cells for cell therapy. Cell Transplant 9, 701-704.
72. Toda, A., Okabe, M., Yoshida, T., and Nikaido, T. (2007). The potential of amniotic membrane/amnion-derived cells for regeneration of various tissues. J Pharmacol Sci 105, 215-228.
73. Tsuji, O., Miura, K., Okada, Y., Fujiyoshi, K., Mukaino, M., Nagoshi, N., Kitamura, K., Kumagai, G., Nishino, M., Tomisato, S., Higashi, H., Nagai, T., Katoh, H., Kohda, K., Matsuzaki, Y., Yuzaki, M., Ikeda, E., Toyama, Y., Nakamura, M., Yamanaka, S., and Okano, H. (2010). Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. Proc Natl Acad Sci U S A 107, 12704-12709.
74. Uchida, S., Inanaga, Y., Kobayashi, M., Hurukawa, S., Araie, M., and Sakuragawa, N. (2000). Neurotrophic function of conditioned medium from human amniotic epithelial cells. J Neurosci Res 62, 585-590.
75. Venkatachalam, S., Palaniappan, T., Jayapal, P.K., Neelamegan, S., Rajan, S.S., and Muthiah, V.P. (2009). Novel neurotrophic factor secreted by amniotic epithelial cells. Biocell 33, 81-89.
76. W.H.O. (2002). World Health Report [Online]. [Accessed http//http://www.who.int/whr/en/.%5D.
77. Wang, Y., Deng, Y., and Zhou, G.Q. (2008). SDF-1alpha/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model. Brain Res 1195, 104-112.
78. Wong, C.H., Jenne, C.N., Lee, W.Y., Leger, C., and Kubes, P. (2011). Functional innervations of hepatic iNKT cells is immunosuppressive following stroke. Science 334, 101-105.
79. Wu, J., Sun, Z., Sun, H.S., Weisel, R.D., Keating, A., Li, Z.H., Feng, Z.P., and Li, R.K. (2008). Intravenously administered bone marrow cells migrate to damaged brain tissue and improve neural function in ischemic rats. Cell Transplant 16, 993-1005.
80. Wu, Z.Y., and Hui, G.Z. (2006). Materials for neuro-transplantation and the amnion. Chin Med J (Engl) 119, 1323-1326.
81. Xi, J., Khalil, M., Shishechian, N., Hannes, T., Pfannkuche, K., Liang, H., Fatima, A., Haustein, M., Suhr, F., Bloch, W., Reppel, M., Saric, T., Wernig, M., Janisch, R., Brockmeier, K., Hescheler, J., and Pillekamp, F. (2010). Comparison of contractile behavior of native murine ventricular tissue and cardiomyocytes derived from embryonic or induced pluripotent stem cells. Faseb J 24, 2739-2751.
82. Xue, S., Chen, C., Dong, W., Hui, G., Liu, T., and Guo, L. (2012). Therapeutic effects of human amniotic epithelial cell transplantation on double-transgenic mice coexpressing APPswe and PS1DeltaE9-deleted genes. Sci China Life Sci 55, 132-140.
83. Yilmaz, G., and Granger, D.N. (2010). Leukocyte recruitment and ischemic brain injury. Neuromolecular Med 12, 193-204.
84. Yu, S.J., Soncini, M., Kaneko, Y., Hess, D.C., Parolini, O., and Borlongan, C.V. (2009). Amnion: a potent graft source for cell therapy in stroke. Cell Transplant 18, 111-118.
85. Zimmermann, S., Voss, M., Kaiser, S., Kapp, U., Waller, C.F., and Martens, U.M. (2003). Lack of telomerase activity in human mesenchymal stem cells. Leukemia 17, 1146-1149.